The use of autologous dendritic cell vaccine in the treatment of chondrosarcomas: a clinical case

U. I. Komarov; Комаров Ю. И.; A. I. Semenova; Семенова А. И.; I. A. Baldueva; Балдуева И. А.; T. L. Nekhaeva; Нехаева Т. Л.; A. V. Novik; Новик А. В.; D. H. Latipova; Латипова Д. Х.; S. A. Procenko; Проценко С. А.

The use of autologous dendritic cell vaccine in the treatment of chondrosarcomas: a clinical case

Authors: Komarov U.I.¹, Semenova A.I.¹, Baldueva I.A.¹, Nekhaeva T.L.¹, Novik A.V.¹, Latipova D.H.¹, Procenko S.A.¹
Affiliations:
1. N.N. Petrov Research Institute of oncology
Issue: Vol 6, No 2 (2014)
Pages: 51-52
Section: EXPERIMENTAL ONCOLOGY
Published: 26.06.2014
URL: https://sarbon.abvpress.ru/jour/article/view/470
ID: 470

Cite item

Full Text

Abstract
About the authors
References
Supplementary files
Statistics

Abstract

Soft tissue sarcomas belong to a rare group of highly malignant tumors that respond poorly to chemotherapy. A case of a 50-year-old male patient suffering from a tibial chondrosarcoma of the soft tissues is presented; the disease progression after first-line chemotherapy was revealed and treatment with autologous dendritic cell vaccine was initiated. During vaccine treatment for 19 months the patient’s condition is stable. his treatment continues.